Plandaí Biotechnology, Inc.
PLPL • Shell Companies
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$4.49M
Growth
-100.0%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Manageable debt level · 0Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out44.89B
Market Cap$4.49M
Enterprise Value$4.65M
52W Range0.00 - 0.00
Beta9.73
P/E-59.09
P/B-76.37
P/FCF0.29
EV/EBITDA-61.22
EV/FCF0.30
Price$0.00
Change0.00%
Shares Out44.89B
Market Cap$4.49M
Enterprise Value$4.65M
52W Range0.00 - 0.00
Beta9.73
P/E-59.09
P/B-76.37
P/FCF0.29
EV/EBITDA-61.22
EV/FCF0.30
Earnings Yield-1.69%
FCF Yield348.31%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.00
Quick Ratio0.00
Revenue 5Y-100.00%
Volume773.64K
Avg Volume17.48K
Investment DNA
How strong this company looks for long-term investors
29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Negative growth trendWeak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.